Literature DB >> 18206197

Membrane association of estrogen receptor alpha and beta influences 17beta-estradiol-mediated cancer cell proliferation.

Maria Marino1, Paolo Ascenzi.   

Abstract

S-Palmitoylation is a widespread post-translational modification of integral and/or peripheral proteins occurring in all eukaryotic cells. The family of S-palmitoylated proteins is large and diverse and recently, estrogen receptor isoforms (ERalpha and ERbeta) belonging to the nuclear receptor superfamily have been added to the palmitoylproteoma. S-Palmitoylation allows ERalpha and ERbeta localization at the plasma membrane, where they associate with caveolin-1. Upon 17beta-estradiol (E2) stimulation, ERalpha dissociates from caveolin-1 allowing the activation of rapid signals relevant for cell proliferation. In contrast to ERalpha, E2 increases ERbeta association with caveolin-1 and activates p38 kinase and the downstream pro-apoptotic cascade (i.e., caspase-3 activation and PARP cleavage). These data highlight the physiological role of palmitoylation in modulating the ERalpha and ERbeta localization at the plasma membrane and the regulation of different E2-induced non-genomic functions relevant for controlling cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18206197     DOI: 10.1016/j.steroids.2007.12.003

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  31 in total

Review 1.  Extranuclear signaling by estrogen: role in breast cancer progression and metastasis.

Authors:  V Cortez; M Mann; D W Brann; R K Vadlamudi
Journal:  Minerva Ginecol       Date:  2010-12

2.  GPR30 FORMS AN INTEGRAL PART OF E2-PROTECTIVE PATHWAY IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS.

Authors:  Sheetal Bodhankar; Halina Offner
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2011-12

Review 3.  Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.

Authors:  Priya Bhardwaj; CheukMan C Au; Alberto Benito-Martin; Heta Ladumor; Sofya Oshchepkova; Ruth Moges; Kristy A Brown
Journal:  J Steroid Biochem Mol Biol       Date:  2019-03-06       Impact factor: 4.292

Review 4.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

Review 5.  Regulation of estrogen receptor beta activity and implications in health and disease.

Authors:  Elin Swedenborg; Krista A Power; Wen Cai; Ingemar Pongratz; Joëlle Rüegg
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

6.  Immune cell-mediated neuroprotection is independent of estrogen action through estrogen receptor-alpha.

Authors:  Junping Xin; Keith N Fargo; Lisa Tanzer; Virginia M Sanders; Kathryn J Jones
Journal:  Metab Brain Dis       Date:  2012-03       Impact factor: 3.584

7.  Oral contraceptives and nicotine synergistically exacerbate cerebral ischemic injury in the female brain.

Authors:  Ami P Raval; Raquel Borges-Garcia; Francisca Diaz; Thomas J Sick; Helen Bramlett
Journal:  Transl Stroke Res       Date:  2013-02-13       Impact factor: 6.829

8.  Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib.

Authors:  Giulia Pinton; Warren Thomas; Paolo Bellini; Arcangela Gabriella Manente; Roberto E Favoni; Brian J Harvey; Luciano Mutti; Laura Moro
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

9.  Enhancement of cell surface expression and receptor functions of membrane progestin receptor α (mPRα) by progesterone receptor membrane component 1 (PGRMC1): evidence for a role of PGRMC1 as an adaptor protein for steroid receptors.

Authors:  Peter Thomas; Yefei Pang; Jing Dong
Journal:  Endocrinology       Date:  2014-01-01       Impact factor: 4.736

10.  Estrogen receptor-alpha 36 mediates the anti-apoptotic effect of estradiol in triple negative breast cancer cells via a membrane-associated mechanism.

Authors:  Reyhaan A Chaudhri; Agreen Hadadi; Kirill S Lobachev; Zvi Schwartz; Barbara D Boyan
Journal:  Biochim Biophys Acta       Date:  2014-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.